We shared our insights on AI's role in advancing antibody therapeutics for cancer in Drug Discovery World Winter issue. 2023 saw remarkable success in the field. AI is key in tackling challenges like difficult-to-drug targets and drug resistance. See pages 50-52: hubs.la/Q02j7p8K0

We will be attending #BIOCEO24 at the end of February; one of the largest investor conferences in #biotech 🇺🇸 We're excited to connect with new potential partners for 2024 🚀 Register now to meet one-to-one: hubs.la/Q02kFvQY0 [email protected] ✉️

Antiverse is attending #BIOEuropeSpring! Join us in Barcelona March 18-20, 2024 🇪🇸 We specialise in making challenging targets druggable. Book a meeting with us through the PartneringONE platform: hubs.la/Q02mm3490 / [email protected] ✉️ #antibodydesign

Challenging targets pose one of the most formidable barriers to our shared vision of a disease-free world. We seek to change this. We are tackling the problems posed by challenging targets with novel machine-learning approaches. 🌐 hubs.la/Q02qm54D0 ✉️ [email protected]

Machine learning emerges as an exciting technology to enhance antibody design capabilities. We are innovating novel solutions to challenging targets like GPCRs, to achieve our shared vision of a disease-free world. #techbio 🌐 hubs.la/Q02rtdBs0 ✉️ [email protected]

We gave our thoughts on how #artificialintelligence is opening new avenues of opportunities in antibody design in Drug Discovery World's Spring Issue release. You can see pages 12-13 for our full breakdown, written by our Co-Founder and CTO, Ben Holland! 🌐 hubs.la/Q02vj1DX0

5 spots left! Hurry! #gpcr #drgpcr

Antiverse is attending #BIO2024 this year, June 3-6 🇺🇸 We specialise in antibody design for challenging targets. Register now to meet our team: hubs.la/Q02xpxLP0 Visit our website: hubs.la/Q02xplDC0 | [email protected] #biotechnology #pharma #partnering

We are #hiring for Senior Machine-Learning Operations Engineers and Senior Software/Data Engineers in Cardiff 🏴󠁧󠁢󠁷󠁬󠁳󠁿 and Prague 🇨🇿 Salary: £70,000 - £90,000 Hybrid Join us in pushing the boundaries of AI and transforming the future of drug discovery! careers.antiverse.io/#jobs

What does AlphaFold 3 mean for antibody discovery? 👩‍🔬🤖 Check out our brief explainer on LinkedIn 🔗linkedin.com/feed/update/ur…

What Will Antibody Discovery Look Like In The Near Future? Find out in our most recent post...⭐️ linkedin.com/posts/antivers…

↓ How to discover antibodies for challenging targets ↓ We developed an AI-driven antibody design platform for GPCRs and other challenging targets. Learn more about how our technology works in these short panels. #artificialintelligence #biologics #techbio

Founding a #biotech start-up isn't easy. Our co-founder and CEO speaks about the challenges he faced during his journey to founding Antiverse. (we design antibodies for challenging targets) Ft. Paul Essery from The Tech Business Podcast. podcasts.apple.com/us/podcast/pau… #FODD #AI

Why are target-specific antibody libraries useful for working with challenging targets? While predictive accuracy is still limited, AI-designed libraries offer a way to begin tackling 'undruggable' targets, like GPCRs and Ion Channels. #biotech #machinelearning #antibody

We're announcing some exciting new job opportunities! ⭐ Senior Business Development Manager ⭐ Operations Manager ⭐ Senior Machine Learning Engineer Join us in pushing the boundaries of AI and transforming the future of drug discovery! hubs.la/Q02JHNxQ0 #hiring

"Naive optimism' is a useful tool to overcome uncertainties and risks of building a start-up. In this segment from our most recent episode of the #FODD podcast, our Co-Founder and CEO shares some wisdom on the challenges of founding a biotech company. #biotech #podcast

We're thrilled to have been one of the first #investors into Antiverse, helping them realise their computational #antibody drug discovery platform. 🌟 Recently we welcomed Ben Holland, their CTO & Co-Founder, as keynote speaker at our EngBio event. 👇 Future Planet Capital #Funding

Check out our most recent #FODD episode with Rahmad Akbar, Senior Data Scientist in Antibody Design Novo Nordisk. We chat about how #artificialintelligence can create new possibilities in antibody design. hubs.la/Q02Nm3Ny0 #antibodydiscovery

Antiverse will be partnering at RESI Boston #RESIBOSTON ! Send us a meeting request at hubs.la/Q02PjH500. We design antibodies for challenging targets. #biotech #pharma

Antiverse is sponsoring the Antibody Therapeutics and AI Drug Discovery hubXchange events next week! We're excited to be speaking with potential partners and collaborators. Join us and hear about our developments in AI and antibody discovery for challenging targets.